ACRS Q3 2019 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$407M

Q3 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$983,000-39.6% YoY

Gross Profit

$157,00016.0% margin

Operating Income

-$23M-2325.9% margin

Net Income

-$55M-5627.6% margin

EPS (Diluted)

$-1.34

QoQ Revenue Growth

-83.2%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$24M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$160M

Total Liabilities

$75M

Stockholders' Equity

$85M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$983,000	$2M	-39.6%
Gross Profit	$157,000	$435,000	-63.9%
Operating Income	-$23M	-$33M	+31.6%
Net Income	-$55M	-$33M	-69.0%

Revenue Segments

Laboratory Research Revenue

$983,000100%